• AXIS Clinicals successfully completes 25th US FDA audit (November 2018)
  • AXIS Clinicals successfully completes 4th MHRA audit (June 2018)
  • AXIS Clinicals successfully completes 2nd WHO audit (December 2017)
  • AXIS Clinicals successfully completes AEMPS Spain (December 2018)
  • AXIS Clinicals successfully completes INFARMED Portugal (June 2018)
  • AXIS Clinicals successfully completes NPRA Malaysia (June 2018)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Medical Writing

Medical writing in the context of Clinical Research undoubtedly plays a crucial role in the success or failure of new compounds. AXIS Clinicals’ medical writing domain is well equipped with professionals having strong academics besides having valuable scientific experience in various therapeutic areas; help to compile, organize, write, edit and produce a wide range of medical and scientific documentation essential to deliver the quality and timeliness required to support the product development efforts.

Our clients can safely bank on our writers at any stage in their product development lifecycle – from clinical development plan and investigator brochures to regulatory submission and licensing maintenance documents. Having in-house expertise from PK|PD to pharmaco-vigilance, we are capable to work on study reports, patient narratives, DSMB updates, labeling or other documents involving study data.

The Medical Writing services at AXIS Clinicals is proficient in:

  • Clinical development plans
  • Abstracts, manuscripts and journal articles
  • Investigator brochures and annual updates
  • Informed consent forms
  • Protocols
  • Clinical study reports
  • Clinical sections of Common Technical Documents (CTDs)
  • Clinical sections of New Drug Applications (NDAs)
  • Periodic Safety Update Reports (PSURs) and other pharmaco-vigilance documents
  • Pre-FDA meeting briefing documents
  • Response to clinical hold orders
  • Preclinical study reports, expert reports and summaries
  • Data Safety Monitoring Board (DSMB) manuals
  • Written and tabular summaries

Bio-Analytical Reporting

  • Method Validation Reports
  • Bio analytical Reports
  • ISR Reports
  • Submission-ready Documentation (Hyperlinked eCTD formatting)
  • Dispatch & Archival
  • Benefit | Risk assessment reports apart from medical and scientific literature reviews

Our unique medical writing offerings are in strict adherence with ICH guidelines and similar regulatory requirements.


Fact sheet

  • 2,600+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experienced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved